Beijing Leadman Biochemistry Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 15.53%

Beijing Leadman Biochemistry Co Ltd (300289) has an Asset Resilience Ratio of 15.53% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Beijing Leadman Biochemistry Co Ltd carry for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥281.00 Million

≈ $41.12 Million USD Cash + Short-term Investments

Total Assets

CN¥1.81 Billion

≈ $264.73 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2023–2024)

This chart shows how Beijing Leadman Biochemistry Co Ltd's Asset Resilience Ratio has changed over time. See net assets of Beijing Leadman Biochemistry Co Ltd for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Beijing Leadman Biochemistry Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Beijing Leadman Biochemistry Co Ltd market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥281.00 Million	15.53%
Total Liquid Assets	CN¥281.00 Million	15.53%

Asset Resilience Insights

Good Liquidity Position: Beijing Leadman Biochemistry Co Ltd maintains a healthy 15.53% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Beijing Leadman Biochemistry Co Ltd Industry Peers by Asset Resilience Ratio

Compare Beijing Leadman Biochemistry Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
INKON Life Technology Co Ltd SHE:300143	Medical Devices	3.37%
CareRay Digital Medical Technology Co Ltd SHG:688607	Medical Devices	16.21%
Senseonics Holdings, Inc. Common Stock NYSE MKT:SENS	Medical Devices	54.67%
Universus Photo Imagings Limited NSE:UNIVPHOTO	Medical Devices	30.97%
HansBiomed Corporation KQ:042520	Medical Devices	9.13%
Aligned Genetics Inc KQ:238120	Medical Devices	2.22%
Heramed Ltd AU:HMD	Medical Devices	0.83%
Acarix A/S ST:ACARIX	Medical Devices	37.81%

Annual Asset Resilience Ratio for Beijing Leadman Biochemistry Co Ltd (2023–2024)

The table below shows the annual Asset Resilience Ratio data for Beijing Leadman Biochemistry Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	17.35%	CN¥316.14 Million ≈ $46.26 Million	CN¥1.82 Billion ≈ $266.68 Million	+2.37pp
2023-12-31	14.98%	CN¥290.29 Million ≈ $42.48 Million	CN¥1.94 Billion ≈ $283.65 Million	--

pp = percentage points

About Beijing Leadman Biochemistry Co Ltd

SHE:300289 China Medical Devices

Market Cap

$534.16 Million

CN¥3.65 Billion CNY

Market Cap Rank

#12204 Global

#3768 in China

Share Price

CN¥6.71

Change (1 day)

-0.74%

52-Week Range

CN¥4.73 - CN¥11.33

All Time High

CN¥23.05